Upgrade to SI Premium - Free Trial

TD Cowen Reiterates Hold Rating on Myriad Genetics (MYGN)

October 20, 2026 12:11 PM
TD Cowen analyst Kyle Boucher reiterated a Hold rating and $4.50 price target on Myriad ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments